Global Donepezil Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Donepezil Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
Donepezil report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Donepezil market is projected to reach US$ 859.5 million in 2034, increasing from US$ 896.9 million in 2022, with the CAGR of -0.6% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Donepezil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Segment by Type
5mg
10mg
23mg
Hospitals
Clinics
Drugstore
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Donepezil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Donepezil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Donepezil industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Donepezil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Donepezil introduction, etc. Donepezil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Donepezil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
Donepezil report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Donepezil market is projected to reach US$ 859.5 million in 2034, increasing from US$ 896.9 million in 2022, with the CAGR of -0.6% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Donepezil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Segment by Type
5mg
10mg
23mg
Segment by Application
Hospitals
Clinics
Drugstore
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Donepezil market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Donepezil, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Donepezil industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Donepezil in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Donepezil introduction, etc. Donepezil Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Donepezil market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices